Is there a place for Thyroid Scintigraphy with Technetium 99 m in the exploration of congenital hypothyroidism in the absence of Iode 123

Author(s):  
Sihem Mensi ◽  
Imen Halloul ◽  
Abir Ezzine ◽  
Raja Sfar ◽  
Manel Nouira ◽  
...  
2012 ◽  
Vol 2012 ◽  
pp. 1-4 ◽  
Author(s):  
Toshio Kahara ◽  
Noboru Igarashi ◽  
Akira Hishinuma ◽  
Yuko Nakanishi ◽  
Akio Uchiyama ◽  
...  

Thyroglobulin gene mutation is a rare cause of congenital hypothyroidism, but thyroglobulin gene mutations are thought to be associated with thyroid cancer development. A 21-year-old Japanese man treated with levothyroxine for congenital hypothyroidism had an enlarged thyroid gland with undetectable serum thyroglobulin despite elevated serum TSH level. The patient was diagnosed with thyroglobulin gene mutation, with compound heterozygosity for Gly304Cys missense mutation and Arg432X nonsense mutation. Ultrasonography showed a hypovascular large tumor in the left lobe that appeared as a cold nodule on thyroid scintigraphy. He underwent total thyroidectomy, but pathological study did not reveal findings of thyroid carcinoma, but rather a hyperplastic nodule with hemorrhage. Strong cytoplasmic thyroglobulin immunostaining was observed, but sodium iodide symporter immunostaining was hardly detected in the hyperplastic nodule. The clinical characteristics of patients with thyroglobulin gene mutations are diverse, and some patients are diagnosed by chance on examination of goiter in adults. The presence of thyroid tumors that appear as cold nodules on thyroid scintigraphy should consider the potential for thyroid carcinoma, if the patient has relatively low serum thyroglobulin concentration in relation to the degree of TSH without thyroglobulin autoantibody.


1995 ◽  
Vol 22 (9) ◽  
pp. 1005-1008 ◽  
Author(s):  
Mahmoud EI-Desouki ◽  
Nasir AI-Jurayyan ◽  
Abdulrahman AI-Nuaim ◽  
Abdullah AI-Herbish ◽  
Abdullah Abo-Bakr ◽  
...  

2006 ◽  
Vol 52 (6) ◽  
pp. 411-415 ◽  
Author(s):  
R. Iranpour ◽  
M. Hashemipour ◽  
M. Amini ◽  
S. M. Talaei ◽  
R. Kelishadi ◽  
...  

2019 ◽  
Vol 106 (1) ◽  
pp. 77-79 ◽  
Author(s):  
Chris Worth ◽  
Beverly Hird ◽  
Lesley Tetlow ◽  
Neville Wright ◽  
Leena Patel ◽  
...  

IntroductionUK screening for congenital hypothyroidism (CH) is based on dried blood spot Thyroid Stimulating Hormone (TSH). Scintigraphy may identify CH subtypes classified as dysplasia, gland in situ (GIS) and ectopia, but is not performed in all centres. We retrospectively investigated the role of scintigraphy to identify CH subtypes in a single tertiary centre cohort.MethodsBabies who screened positive for CH between 2007 and 2017 were studied (n=418 of 534 783). Scintigraphy outcomes were correlated with TSH and levothyroxine dose. GIS patients were analysed for 3-year outcomes.Results303 patients started levothyroxine. Scintigraphy demonstrated three subtypes: GIS (n=139, 46%) ectopia (n=84, 28%) and dysplasia (n=80, 26%). Three-year follow up demonstrated permanence in 54% of 37 GIS cases.DiscussionThyroid scintigraphy differentiates subtypes of CH and suggests a higher than expected proportion of patients with GIS and ectopia. CH is permanent in half of those with GIS.


PEDIATRICS ◽  
2004 ◽  
Vol 114 (6) ◽  
pp. e683-e688 ◽  
Author(s):  
E. J. Schoen ◽  
W. Clapp ◽  
T. T. To ◽  
B. H. Fireman

2018 ◽  
Author(s):  
Elfrida Kote Ollomani ◽  
Ada Pema

Sign in / Sign up

Export Citation Format

Share Document